{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:03:40Z","timestamp":1763388220454,"version":"3.45.0"},"reference-count":31,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.25122\/jml-2025-0103","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:00:41Z","timestamp":1763388041000},"page":"640-647","source":"Crossref","is-referenced-by-count":0,"title":["Real-world characteristics of systemic mastocytosis in Romania: insights from a reference-center-based descriptive study"],"prefix":"10.25122","volume":"18","author":[{"given":"Horia","family":"Bumbea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Dermatology and Allergology, Elias Emergency University Hospital, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia","family":"Soare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Bone Marrow Transplantation Unit, University Emergency Hospital Bucharest, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Scientific Research Methodology and Hematology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Soare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Bone Marrow Transplantation Unit, University Emergency Hospital Bucharest, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Scientific Research Methodology and Hematology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Br\u00eendu\u0219a","family":"Petru\u021bescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Allergology, University Emergency Hospital Bucharest, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana","family":"Firescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Dermatology, University Emergency Hospital Bucharest, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poliana","family":"Leru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Allergology Department, Colentina Clinical Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Clinical Department 5, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corina Silvia","family":"Pop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Gastroenterology II, University Emergency Hospital Bucharest, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Internal Medicine III and Gastroenterology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucian","family":"Negreanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Gastroenterology I, University Emergency Hospital Bucharest, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Internal Medicine I and Gastroenterology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vlad","family":"Voiculescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Oncological Dermatology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Dermatology and Allergology, Elias Emergency University Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","reference":[{"issue":"7","key":"ref1","first-page":"1703","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia 2022 36:7","volume":"36","author":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF","year":"2022","unstructured":"1. Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia 2022 36:7, [Internet], 2022;36(7):1703-19Available from: https:\/\/www.nature.com\/articles\/s41375-022-01613-1","journal-title":"[Internet]"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2340\/1651-226X.2024.31406","article-title":"Epidemiology of mastocytosis: a population-based study (Sweden)","volume":"63","author":"Bergstr\u00f6m A, H\u00e4gglund H, Berglund A, Nilsson G, Lambe M","year":"2024","unstructured":"2. Bergstr\u00f6m A, H\u00e4gglund H, Berglund A, Nilsson G, Lambe M, Epidemiology of mastocytosis: a population-based study (Sweden), Acta Oncol, 2024;6344-50","journal-title":"Acta Oncol"},{"issue":"24","key":"ref3","doi-asserted-by":"publisher","first-page":"6380","DOI":"10.3390\/cancers13246380","article-title":"A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years' Experience of the GISM Network","volume":"13","author":"Zanotti R, Bonifacio M, Isolan C, Tanasi I, Crosera L, Olivieri F","year":"2021","unstructured":"3. Zanotti R, Bonifacio M, Isolan C, Tanasi I, Crosera L, Olivieri F, A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years' Experience of the GISM Network, Cancers (Basel), 2021;13(24):6380","journal-title":"Cancers (Basel)"},{"issue":"2","key":"ref4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","article-title":"Epidemiology, prognosis, and risk factors in mastocytosis","volume":"34","author":"Brockow K","year":"2014","unstructured":"4. Brockow K, Epidemiology, prognosis, and risk factors in mastocytosis, Immunol Allergy Clin North Am, 2014;34(2):283-95","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"ref5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"Cohen SS, Skovbo S, Vestergaard H, Kristensen T, M\u00f8ller M, Bindslev-Jensen C","year":"2014","unstructured":"5. Cohen SS, Skovbo S, Vestergaard H, Kristensen T, M\u00f8ller M, Bindslev-Jensen C, Epidemiology of systemic mastocytosis in Denmark, Br J Haematol, 2014;166(4):521-8","journal-title":"Br J Haematol"},{"issue":"1","key":"ref6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/bjh.13560","article-title":"Concurrent activating KIT mutations in systemic mastocytosis","volume":"173","author":"Lasho T, Finke C, Zblewski D, Hanson CA, Ketterling RP, Butterfield JH","year":"2016","unstructured":"6. Lasho T, Finke C, Zblewski D, Hanson CA, Ketterling RP, Butterfield JH, Concurrent activating KIT mutations in systemic mastocytosis, Br J Haematol, 2016;173(1):153-6","journal-title":"Br J Haematol"},{"issue":"20","key":"ref7","doi-asserted-by":"publisher","first-page":"10885","DOI":"10.3390\/ijms252010885","article-title":"Detection of KIT Mutations in Systemic Mastocytosis: How, When, and Why","volume":"25","author":"Cilloni D, Maffeo B, Savi A, Danzero AC, Bonuomo V, Fava C","year":"2024","unstructured":"7. Cilloni D, Maffeo B, Savi A, Danzero AC, Bonuomo V, Fava C, Detection of KIT Mutations in Systemic Mastocytosis: How, When, and Why, Int J Mol Sci, 2024;25(20):10885","journal-title":"Int J Mol Sci"},{"issue":"10","key":"ref8","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1093\/annonc\/mdx290","article-title":"Midostaurin: a magic bullet that blocks mast cell expansion and activation","volume":"28","author":"Valent P, Akin C, Hartmann K, George TI, Sotlar K, Peter B","year":"2017","unstructured":"8. Valent P, Akin C, Hartmann K, George TI, Sotlar K, Peter B, Midostaurin: a magic bullet that blocks mast cell expansion and activation, Ann Oncol, 2017;28(10):2367-2376","journal-title":"Ann Oncol"},{"issue":"26","key":"ref9","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","article-title":"Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis","volume":"374","author":"Gotlib J, Kluin-Nelemans HC, George TI, Akin C, Sotlar K, Hermine O","year":"2016","unstructured":"9. Gotlib J, Kluin-Nelemans HC, George TI, Akin C, Sotlar K, Hermine O, Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis, N Engl J Med, 2016;374(26):2530-41","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1182\/blood-2021-146873","article-title":"Efficacy of avapritinib in patients with advanced systemic mastocytosis: hematologic and bone marrow responses from the phase 2 open-label, single-arm PATHFINDER study","volume":"138","author":"George TI, Karner KH, Moser KA, Rets A, Fredericks M, Reiter A, Radia DH, Deininger MW, Lin HM, Sen J, Gotlib J, Dimitrijevi\u0107 S, DeAngelo DJ","year":"2021","unstructured":"10. George TI, Karner KH, Moser KA, Rets A, Fredericks M, Reiter A, Radia DH, Deininger MW, Lin HM, Sen J, Gotlib J, Dimitrijevi\u0107 S, DeAngelo DJ, Efficacy of avapritinib in patients with advanced systemic mastocytosis: hematologic and bone marrow responses from the phase 2 open-label, single-arm PATHFINDER study, Blood, 2021;138(Suppl 1):2565","journal-title":"Blood"},{"issue":"4","key":"ref11","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41375-019-0632-4","article-title":"Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry","volume":"34","author":"Kluin-Nelemans HC, Reiter A, Illerhaus A, van Anrooij B, Hartmann K, Span LFR","year":"2020","unstructured":"11. Kluin-Nelemans HC, Reiter A, Illerhaus A, van Anrooij B, Hartmann K, Span LFR, Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry, Leukemia, 2020;34(4):1090-1101","journal-title":"Leukemia"},{"issue":"4","key":"ref12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/cyto.b.21336","article-title":"Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis","volume":"90","author":"Cherian S, McCullouch V, Miller V, Dougherty K, Fromm JR, Wood BL","year":"2016","unstructured":"12. Cherian S, McCullouch V, Miller V, Dougherty K, Fromm JR, Wood BL, Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis, Cytometry B Clin Cytom, 2016;90(4):387-92","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"ref13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/modpathol.2011.192","article-title":"Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and\/or CD2' WHO criterion","volume":"25","author":"Morgado JM, S\u00e1nchez-Mu\u00f1oz L, Teod\u00f3sio CG, Jara-Acevedo M, Alvarez-Twose I, Matito A","year":"2012","unstructured":"13. Morgado JM, S\u00e1nchez-Mu\u00f1oz L, Teod\u00f3sio CG, Jara-Acevedo M, Alvarez-Twose I, Matito A, Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and\/or CD2' WHO criterion, Mod Pathol, 2012;25(4):516-21","journal-title":"Mod Pathol"},{"issue":"9","key":"ref14","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.5858\/arpa.2013-0537-OA","article-title":"Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow","volume":"138","author":"Jabbar KJ, Medeiros LJ, Wang SA, Miranda RN, Johnson MR, Verstovsek S, Jorgensen JL","year":"2014","unstructured":"14. Jabbar KJ, Medeiros LJ, Wang SA, Miranda RN, Johnson MR, Verstovsek S, Jorgensen JL, Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow, Arch Pathol Lab Med, 2014;138(9):1210-4","journal-title":"Arch Pathol Lab Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/0471142956.cy0606s12","article-title":"Immunophenotypic analysis of human mast cells by flow cytometry","author":"Escribano L, Naval\u00f3n R, N\u00fa\u00f1ez R, D\u00edaz Agust\u00edn B, Bravo P","year":"2001","unstructured":"15. Escribano L, Naval\u00f3n R, N\u00fa\u00f1ez R, D\u00edaz Agust\u00edn B, Bravo P, Immunophenotypic analysis of human mast cells by flow cytometry, Curr Protoc Cytom, 2001;Chapter 6:Unit 6.6","journal-title":"Curr Protoc Cytom"},{"issue":"2","key":"ref16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.iac.2014.01.008","article-title":"Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool","volume":"34","author":"S\u00e1nchez-Mu\u00f1oz L, Teodosio C, Morgado JM, Perbellini O, Mayado A, Alvarez-Twose I","year":"2014","unstructured":"16. S\u00e1nchez-Mu\u00f1oz L, Teodosio C, Morgado JM, Perbellini O, Mayado A, Alvarez-Twose I, Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool, Immunol Allergy Clin North Am, 2014;34(2):297-313","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"ref17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/cea.12225","article-title":"High prevalence of anaphylaxis in patients with systemic mastocytosis-a single-centre experience","volume":"44","author":"G\u00fclen T, H\u00e4gglund H, Dahl\u00e9n B, Nilsson G","year":"2014","unstructured":"17. G\u00fclen T, H\u00e4gglund H, Dahl\u00e9n B, Nilsson G, High prevalence of anaphylaxis in patients with systemic mastocytosis-a single-centre experience, Clin Exp Allergy, 2014;44(1):121-9","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"ref18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10654-024-01195-5","article-title":"Prevalence and incidence of mastocytosis in adults: a Danish nationwide register study","volume":"40","author":"J\u00f8rgensen MP, \u00d8vlisen AK, Jensen JF, El-Galaly TC, Dalager MG, Vestergaard H","year":"2025","unstructured":"18. J\u00f8rgensen MP, \u00d8vlisen AK, Jensen JF, El-Galaly TC, Dalager MG, Vestergaard H, Prevalence and incidence of mastocytosis in adults: a Danish nationwide register study, Eur J Epidemiol, 2025;40(1):43-53","journal-title":"Eur J Epidemiol"},{"issue":"8","key":"ref19","doi-asserted-by":"publisher","first-page":"E209","DOI":"10.1002\/ajh.26963","article-title":"ICC-2022 versus WHO-2022 classification systems for acute leukemias and myeloid neoplasms: The perspective from two classical morphologists","volume":"98","author":"Zini G, Bennett JM","year":"2023","unstructured":"19. Zini G, Bennett JM, ICC-2022 versus WHO-2022 classification systems for acute leukemias and myeloid neoplasms: The perspective from two classical morphologists, Am J Hematol, 2023;98(8):E209-E211","journal-title":"Am J Hematol"},{"issue":"8","key":"ref20","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.jaip.2022.03.007","article-title":"Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice","volume":"10","author":"Valent P, Hartmann K, Schwaab J, Alvarez-Twose I, Brockow K, Bonadonna P","year":"2022","unstructured":"20. Valent P, Hartmann K, Schwaab J, Alvarez-Twose I, Brockow K, Bonadonna P, Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice, J Allergy Clin Immunol Pract, 2022;10(8):1999-2012.e6","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"ref21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/s0889-8588(05)70300-2","article-title":"Serum tryptase and the laboratory diagnosis of systemic mastocytosis","volume":"14","author":"Schwartz LB, Irani AM","year":"2000","unstructured":"21. Schwartz LB, Irani AM, Serum tryptase and the laboratory diagnosis of systemic mastocytosis, Hematol Oncol Clin North Am, 2000;14(3):641-57","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"ref22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.iac.2014.01.011","article-title":"Bone involvement and osteoporosis in mastocytosis","volume":"34","author":"Rossini M, Zanotti R, Viapiana O, Tripi G, Orsolini G, Idolazzi L","year":"2014","unstructured":"22. Rossini M, Zanotti R, Viapiana O, Tripi G, Orsolini G, Idolazzi L, Bone involvement and osteoporosis in mastocytosis, Immunol Allergy Clin North Am, 2014;34(2):383-96","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"ref23","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/ajd.13443","article-title":"Cutaneous mastocytosis: A dermatological perspective","volume":"62","author":"Di Raimondo C, Del Duca E, Silvaggio D, Di Prete M, Lombardo P, Mazzeo M","year":"2021","unstructured":"23. Di Raimondo C, Del Duca E, Silvaggio D, Di Prete M, Lombardo P, Mazzeo M, Cutaneous mastocytosis: A dermatological perspective, Australas J Dermatol, 2021;62(1):e1-e7","journal-title":"Australas J Dermatol"},{"issue":"11","key":"ref24","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent P, Akin C, Metcalfe DD","year":"2017","unstructured":"24. Valent P, Akin C, Metcalfe DD, Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts, Blood, 2017;129(11):1420-1427","journal-title":"Blood"},{"issue":"26","key":"ref25","doi-asserted-by":"publisher","first-page":"5812","DOI":"10.1182\/blood-2010-08-292144","article-title":"How I treat patients with advanced systemic mastocytosis","volume":"116","author":"Valent P, Sperr WR, Akin C","year":"2010","unstructured":"25. Valent P, Sperr WR, Akin C, How I treat patients with advanced systemic mastocytosis, Blood, 2010;116(26):5812-7","journal-title":"Blood"},{"issue":"16","key":"ref26","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1182\/blood-2013-01-453183","article-title":"How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage)","volume":"121","author":"Pardanani A","year":"2013","unstructured":"26. Pardanani A, How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage), Blood, 2013;121(16):3085-94","journal-title":"Blood"},{"issue":"1","key":"ref27","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/ajh.25302","article-title":"Smoldering mastocytosis: Survival comparisons with indolent and aggressive mastocytosis","volume":"94","author":"Tefferi A, Shah S, Reichard KK, Hanson CA, Pardanani A","year":"2019","unstructured":"27. Tefferi A, Shah S, Reichard KK, Hanson CA, Pardanani A, Smoldering mastocytosis: Survival comparisons with indolent and aggressive mastocytosis, Am J Hematol, 2019;94(1):E1-E2","journal-title":"Am J Hematol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2340\/1651-226X.2024.31406","article-title":"Epidemiology of mastocytosis: a population-based study (Sweden)","volume":"63","author":"Bergstr\u00f6m A, H\u00e4gglund H, Berglund A, Nilsson G, Lambe M","year":"2024","unstructured":"28. Bergstr\u00f6m A, H\u00e4gglund H, Berglund A, Nilsson G, Lambe M, Epidemiology of mastocytosis: a population-based study (Sweden), Acta Oncol, 2024;6344-50","journal-title":"Acta Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.leukres.2017.05.018","article-title":"Mast cell leukemia (MCL): Clinico-pathologic and molecular features and survival outcome","volume":"59","author":"Jain P, Wang S, Patel KP, Sarwari N, Cortes J, Kantarjian H","year":"2017","unstructured":"29. Jain P, Wang S, Patel KP, Sarwari N, Cortes J, Kantarjian H, Mast cell leukemia (MCL): Clinico-pathologic and molecular features and survival outcome, Leuk Res, 2017;59105-109","journal-title":"Leuk Res"},{"issue":"8","key":"ref30","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/all.14248","article-title":"Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification","volume":"75","author":"Trizuljak J, Sperr WR, Nekvindov\u00e1 L, Elberink HO, Gleixner KV, Gorska A","year":"2020","unstructured":"30. Trizuljak J, Sperr WR, Nekvindov\u00e1 L, Elberink HO, Gleixner KV, Gorska A, Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification, Allergy, 2020;75(8):1927-1938","journal-title":"Allergy"},{"issue":"2","key":"ref31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/MOH.0b013e3283366c59","article-title":"Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature","volume":"17","author":"Pardanani A, Tefferi A","year":"2010","unstructured":"31. Pardanani A, Tefferi A, Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature, Curr Opin Hematol, 2010;17(2):125-32","journal-title":"Curr Opin Hematol"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-7-2025\/original-article-issue-7-2025\/real-world-characteristics-of-systemic-mastocytosis-in-romania-insights-from-a-reference-center-based-descriptive-study\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:00:49Z","timestamp":1763388049000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-7-2025\/original-article-issue-7-2025\/real-world-characteristics-of-systemic-mastocytosis-in-romania-insights-from-a-reference-center-based-descriptive-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["JMedLife-18-640"],"URL":"https:\/\/doi.org\/10.25122\/jml-2025-0103","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}